Back to results
US 2012/0252856 A1Published application
Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
AssigneeDignity Health
InventorsAnna Joy, Burt G. Feuerstein, Ivan Smimov
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of dividing cancer into subgroups based upon Akt pathway gene expression. In one embodiment, the present invention provides a method of diagnosing glioblastoma multiforme (GBM) subtype in an individual by determining the presence of an abnormal expression of an Akt pathway gene cluster and diagnosing the cancer subtype in the individual.
Claims21
A method of diagnosing a cancer subtype in an individual, comprising:
- determining the presence or absence of an abnormal expression of an Akt pathway gene cluster in the individual;
- and
- diagnosing the cancer subtype based on the presence of the abnormal expression of the Akt pathway gene cluster in the individual.
A method of treating cancer in an individual, comprising:
- diagnosing a cancer subtype in the individual based on a cluster of Akt pathway gene expression;
- and
- treating the individual.
A method of diagnosing a tumor subtype, comprising:
- obtaining a tumor sample from an individual;
- assaying the tumor sample to determine the presence or absence of an abnormal expression of an Akt pathway gene cluster;
- and
- diagnosing the tumor subtype based on the presence of the abnormal expression of the Akt pathway gene cluster.
1 more element
Dependencies are inferred from the claim text.